Dexcom announced today that it’s preparing updates to its two mobile apps that will allow users of its Continuous Glucose Monitor System to track everything straight from Apple Watch. The apps will ...

DEXCOM G4 PLATINUM continuous glucose monitor by Dexcom Dexcom announced that the FDA has approved its Dexcom G4 Platinum continuous glucose monitor (CGM) for patients with diabetes. Dexcom announced ...

SAN DIEGO--(BUSINESS WIRE)--Dexcom (NASDAQ: DXCM), a leader in continuous glucose monitoring, announced today that the U.S. Food and Drug Administration has approved its eagerly anticipated new ...

The US Food and Drug Administration (FDA) has approved a new insulin pump/continuous glucose monitor (CGM) product, Tandem's t:slim Insulin Pump and Dexcom G4 PLATINUM CGM System, according to a ...

The Julphar revolutionary real-time continuous glucose monitoring device (CGM), DEXCOM G4 PLATINUM is now available in UAE, KSA, Kuwait and Oman and will soon be available in Qatar, Bahrain and ...

Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...

DexCom’s shares shot up as much as 8% in the trading session following the announcement. The stock has been up 2.6% since the news release. Currently, the DexCom G4 PLATINUM (Pediatric) is the only ...

Dexcom ($DXCM) won FDA approval for its next-generation mobile communications device for diabetes monitoring, chalking up another regulatory win and furthering the ...

New products in development with partners Johnson & Johnson and Tandem could help Dexcom outmaneuver its chief competitor, Medtronic. More than 365 million people have diabetes worldwide and estimates ...